CAM
MRNA icon

Cubic Asset Management’s Moderna MRNA Stock Holding History

Cubic Asset Management’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		$397K Sell
3,725
-200
-5% -$20.2K 0.09% 152
2023
Q4 		$390K Buy
3,925
+700
+22% +$58.9K 0.1% 155
2023
Q3 		$333K Buy
+3,225
New +$360K 0.09% 159

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Cubic Asset Management's MRNA Position: Q1 2024 in Review

Cubic Asset Management reduced its Moderna (MRNA) stake by 5.1% in Q1 2024, selling an estimated $20.2K and leaving 3,725 shares worth $397K. The position accounts for 0.09% of the portfolio, ranked #152.

Cubic Asset Management first reported a position in MRNA in Q3 2023 and has held it in 3 quarters since. 902 funds tracked by Wall St. Rank hold MRNA as of Q1 2024.

  • Cubic Asset Management held 3,725 shares of Moderna worth $397K as of Q1 2024.
  • Cubic Asset Management sold 200 Moderna shares in Q1 2024, an estimated $20.2K.
  • Moderna made up 0.09% of Cubic Asset Management's portfolio in Q1 2024, its #152 holding.
  • Cubic Asset Management first reported a position in Moderna in Q3 2023 and has held it in 3 quarters since.
  • 902 funds tracked by Wall St. Rank held Moderna as of Q1 2024.

Based on Cubic Asset Management's 13F filing for Q1 2024, filed 24 Apr 2024.